Katherine High, MD has enjoyed a 30+ year career in internal medicine, hematology, molecular genetics, and gene therapy. She served as the inaugural director of a Center at The Children’s Hospital of Philadelphia and an Investigator of the Howard Hughes Medical Institute. Dr. High also served a 5-year term on the U.S. FDA Advisory Committee on Cell, Tissue and Gene Therapies and is a past president of the American Society of Gene & Cell Therapy. In 2013, she co-founded Spark Therapeutics and, following Spark’s acquisition by Roche, left the organization to serve as a Visiting Professor at Rockefeller University. In 2021, she joined AskBio as President, Therapeutics, and serves as a member of the AskBio Board of Directors. Dr. High received her bachelor’s degree in chemistry from Harvard University, an MD from the University of North Carolina School of Medicine, a business certification from the University of North Carolina Business School’s Management Institute for Hospital Administrators and a master’s degree from the University of Pennsylvania. She is an elected member of the National Academy of Medicine, the American Academy of Arts and Sciences, and the faculty of Pharmaceutical Medicine of the Royal College of Physicians (London).